Feng Zhang's CRISPR startup Aera shrinks headcount by a quarter
04 Jan 2024
Acquisition
Genetic medicine startup Aera Therapeutics, which emerged last February with $193 million, has laid off 25% of its staff, a spokesperson confirmed to Endpoints News Thursday afternoon.
The Boston startup is built on work out of CRISPR pioneer Feng Zhang and the University of Utah’s Jason Shepherd, and it had reeled in some of the biggest biotech venture backers like ARCH and GV.
The layoffs come the same day another Zhang startup was publicly launched with $57 million for epigenetic biotech Moonwalk Biosciences.
Preview
Source: EndPoints
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.